Shares of C3.ai Inc. AI slipped 1.98% to $23.25 Friday, on what proved to be an all-around mixed trading session for the ...

After listening to the enterprise AI specialist's latest earnings call, I have some concerns over where the company is headed ...

C3.ai is implementing a successful strategy to increase customer counts. Fool.com contributor and finance professor Parkev ...

Shares of C3.ai Inc. AI sank 0.26% to $23.27 Wednesday, on what proved to be an all-around grim trading session for the stock ...

C3.ai's growth is fairly modest given its size and the strength of the demand environment. Read why I remain neutral on AI ...

Cannabinoid-focused biopharmaceutical company C3 Pharmaceuticals announces a planned listing on the Canadian Securities ...

Enterprises and institutions are rushing to develop an AI strategy, which will be a tailwind for these two AI stocks.

The new iteration of C3 Pharmaceuticals, Inc. announced that it executed a tailored Share Subscription Agreement (SSA) with ...

Following the drop in its stock price, C3.ai trades at a forward price-to-sales (P/S) ratio that is just about 7 based on ...

C3.ai, Inc. (AI) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

Executives are fighting back against a federal court decision that banned them from the securities industry and ordered them ...

We recently published a list of 10 AI News and Analyst Ratings You Should Not Miss. Since C3.ai Inc (NYSE:AI) ranks 10th on ...